chrX-110198562-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_015365.3(AMMECR1):āc.960T>Cā(p.Asn320Asn) variant causes a synonymous change. The variant allele was found at a frequency of 0.00508 in 1,200,325 control chromosomes in the GnomAD database, including 9 homozygotes. There are 1,858 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0028 ( 1 hom., 75 hem., cov: 22)
Exomes š: 0.0053 ( 8 hom. 1783 hem. )
Consequence
AMMECR1
NM_015365.3 synonymous
NM_015365.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.75
Genes affected
AMMECR1 (HGNC:467): (AMMECR nuclear protein 1) The exact function of this gene is not known, however, submicroscopic deletion of the X chromosome including this gene, COL4A5, and FACL4 genes, result in a contiguous gene deletion syndrome, the AMME complex (Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant X-110198562-A-G is Benign according to our data. Variant chrX-110198562-A-G is described in ClinVar as [Benign]. Clinvar id is 779292.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 75 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMMECR1 | NM_015365.3 | c.960T>C | p.Asn320Asn | synonymous_variant | 6/6 | ENST00000262844.10 | NP_056180.1 | |
AMMECR1 | NM_001025580.2 | c.849T>C | p.Asn283Asn | synonymous_variant | 5/5 | NP_001020751.1 | ||
AMMECR1 | NM_001171689.2 | c.591T>C | p.Asn197Asn | synonymous_variant | 8/8 | NP_001165160.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMMECR1 | ENST00000262844.10 | c.960T>C | p.Asn320Asn | synonymous_variant | 6/6 | 1 | NM_015365.3 | ENSP00000262844.5 |
Frequencies
GnomAD3 genomes AF: 0.00276 AC: 308AN: 111769Hom.: 1 Cov.: 22 AF XY: 0.00221 AC XY: 75AN XY: 33949
GnomAD3 genomes
AF:
AC:
308
AN:
111769
Hom.:
Cov.:
22
AF XY:
AC XY:
75
AN XY:
33949
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00284 AC: 478AN: 168581Hom.: 0 AF XY: 0.00273 AC XY: 149AN XY: 54533
GnomAD3 exomes
AF:
AC:
478
AN:
168581
Hom.:
AF XY:
AC XY:
149
AN XY:
54533
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00532 AC: 5788AN: 1088556Hom.: 8 Cov.: 28 AF XY: 0.00502 AC XY: 1783AN XY: 355384
GnomAD4 exome
AF:
AC:
5788
AN:
1088556
Hom.:
Cov.:
28
AF XY:
AC XY:
1783
AN XY:
355384
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00276 AC: 308AN: 111769Hom.: 1 Cov.: 22 AF XY: 0.00221 AC XY: 75AN XY: 33949
GnomAD4 genome
AF:
AC:
308
AN:
111769
Hom.:
Cov.:
22
AF XY:
AC XY:
75
AN XY:
33949
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at